Tjon, A S W <br/><br/>
Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.  [electronic resource] 

 -  Clinical and experimental immunology  Aug 2013 
 - 259-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/cei.12102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Autoimmune Diseases--drug therapy<br/>CD4 Antigens--metabolism<br/>Clinical Protocols<br/>Drug Dosage Calculations<br/>Female<br/>Forkhead Transcription Factors--metabolism<br/>HLA-DR Antigens--genetics<br/>Humans<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunologic Deficiency Syndromes--drug therapy<br/>Immunosuppression Therapy<br/>Interleukin-2 Receptor alpha Subunit--metabolism<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Middle Aged<br/>T-Lymphocytes, Helper-Inducer--drug effects<br/>T-Lymphocytes, Regulatory--drug effects<br/>Young Adult